Literature DB >> 15371457

Syndecan-4 regulates ATF-2 transcriptional activity in a Rac1-dependent manner.

Stefania Saoncella1, Enzo Calautti, Wendy Neveu, Paul F Goetinck.   

Abstract

Syndecan-4 is a transmembrane heparan sulfate proteoglycan that co-operates with integrins during cell-matrix interactions for the assembly of focal adhesions and actin stress fibers and in the phosphorylation of focal adhesion kinase (FAK) on Tyr397. These cellular events are regulated by the small GTPase Rho, and in the absence of syndecan-4 ligation, cellular levels of GTP-bound Rho are decreased implicating syndecan-4 in the regulation of the small GTPases. In the present study we report that, compared with wild type cells, fibronectin-adherent syndecan-4-null fibroblasts showed enhanced lamellipodia and increased Rac1 activity that could be down-regulated by re-expression of syndecan-4 in the mutant cells. Consistent with the role for Rac1 in activating p38 and JNK signaling, syndecan-4-null cells display higher levels of active p38 MAPK and JNK that were abolished by the expression of a dominant-negative RacN17 mutant. Since p38 and JNK regulate gene expression by phosphorylating and activating transcription factors, we compared both the phosphorylation state and the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17. Our results reveal a novel function for syndecan-4 in modulating nuclear transcriptional activity and indicate an underlying mechanism that acts at the level of Rac1-p38/JNK signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371457     DOI: 10.1074/jbc.C400299200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Directional cell migration in vivo: Wnt at the crest.

Authors:  Carlos Carmona-Fontaine; Helen Matthews; Roberto Mayor
Journal:  Cell Adh Migr       Date:  2008-10-05       Impact factor: 3.405

2.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Authors:  Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

3.  Therapeutic ultrasound bypasses canonical syndecan-4 signaling to activate rac1.

Authors:  Claire M Mahoney; Mark R Morgan; Andrew Harrison; Martin J Humphries; Mark D Bass
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

4.  A novel role for activating transcription factor-2 in 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis.

Authors:  Tieqiang Zhao; Dong Wang; Sergey Y Cheranov; Manjula Karpurapu; Koteswara R Chava; Venkatesh Kundumani-Sridharan; Dianna A Johnson; John S Penn; Gadiparthi N Rao
Journal:  J Lipid Res       Date:  2008-10-10       Impact factor: 5.922

Review 5.  Synergistic control of cell adhesion by integrins and syndecans.

Authors:  Mark R Morgan; Martin J Humphries; Mark D Bass
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

6.  The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.

Authors:  Aniko Keller-Pinter; Bettina Ughy; Monika Domoki; Aladar Pettko-Szandtner; Tamas Letoha; Jozsef Tovari; Jozsef Timar; Laszlo Szilak
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

7.  Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway.

Authors:  Jun Ge; Xiaoqiang Cheng; Chenxi Yuan; Jiale Qian; Chunshen Wu; Cheng Cao; Huilin Yang; Feng Zhou; Jun Zou
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

8.  Myoblast Migration and Directional Persistence Affected by Syndecan-4-Mediated Tiam-1 Expression and Distribution.

Authors:  Daniel Becsky; Szuzina Gyulai-Nagy; Arpad Balind; Peter Horvath; Laszlo Dux; Aniko Keller-Pinter
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

9.  Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Authors:  Arye Elfenbein; John M Rhodes; Julia Meller; Martin A Schwartz; Michiyuki Matsuda; Michael Simons
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

10.  Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix.

Authors:  Mark D Bass; Kirsty A Roach; Mark R Morgan; Zohreh Mostafavi-Pour; Tobias Schoen; Takashi Muramatsu; Ulrike Mayer; Christoph Ballestrem; Joachim P Spatz; Martin J Humphries
Journal:  J Cell Biol       Date:  2007-05-07       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.